DK2109608T3 - Amide-substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors - Google Patents

Amide-substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors

Info

Publication number
DK2109608T3
DK2109608T3 DK08702101.0T DK08702101T DK2109608T3 DK 2109608 T3 DK2109608 T3 DK 2109608T3 DK 08702101 T DK08702101 T DK 08702101T DK 2109608 T3 DK2109608 T3 DK 2109608T3
Authority
DK
Denmark
Prior art keywords
parp
adp
ribose
polymerase
inhibitors
Prior art date
Application number
DK08702101.0T
Other languages
Danish (da)
Inventor
Philip Jones
Ontoria Jesus Maria Ontoria
Rita Scarpelli
Carsten Schultz-Fademrecht
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37809722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2109608(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Priority claimed from PCT/GB2008/050018 external-priority patent/WO2008084261A1/en
Application granted granted Critical
Publication of DK2109608T3 publication Critical patent/DK2109608T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts, stereoisomers or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory discuses, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage or skin senescence and UV-induced skin damage, and as chemo and/or radiosensitizers for cancer treatment.
DK08702101.0T 2007-01-10 2008-01-08 Amide-substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors DK2109608T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0700432.8A GB0700432D0 (en) 2007-01-10 2007-01-10 Therapeutic compounds
US92131007P 2007-04-02 2007-04-02
PCT/GB2008/050018 WO2008084261A1 (en) 2007-01-10 2008-01-08 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors

Publications (1)

Publication Number Publication Date
DK2109608T3 true DK2109608T3 (en) 2011-07-11

Family

ID=37809722

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11157369.7T DK2336120T3 (en) 2007-01-10 2008-01-08 COMBINATIONS CONTAINING AMID-SUBSTITUTED INDAZOLES AS POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS
DK08702101.0T DK2109608T3 (en) 2007-01-10 2008-01-08 Amide-substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK11157369.7T DK2336120T3 (en) 2007-01-10 2008-01-08 COMBINATIONS CONTAINING AMID-SUBSTITUTED INDAZOLES AS POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS

Country Status (21)

Country Link
CN (1) CN101578279B (en)
AT (1) ATE502933T1 (en)
CR (1) CR10910A (en)
DE (1) DE602008005711D1 (en)
DK (2) DK2336120T3 (en)
ES (3) ES2362214T3 (en)
GB (1) GB0700432D0 (en)
HN (1) HN2009001260A (en)
HU (1) HUE044513T2 (en)
LT (1) LT2805945T (en)
LU (1) LUC00072I2 (en)
ME (1) ME03481B (en)
MY (1) MY147789A (en)
NI (1) NI200900135A (en)
NZ (1) NZ578256A (en)
PE (1) PE20081558A1 (en)
PT (3) PT2805945T (en)
SI (2) SI2109608T1 (en)
TW (1) TWI528961B (en)
UA (1) UA97658C2 (en)
ZA (1) ZA200903898B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106496187A (en) * 2016-09-14 2017-03-15 陕西科技大学 A kind of synthetic method for preparing PARP inhibitor Niraparib
CN106432188A (en) * 2016-09-17 2017-02-22 青岛辰达生物科技有限公司 Preparation method of anti-cancer drug 2-[4-((3S)-3-Piperidinyl) phenyl]-2H-Indazole-7-Formamide
CN106432187A (en) * 2016-09-17 2017-02-22 青岛云天生物技术有限公司 Chiral resolution method of 2-[4-(-3-piperidyl)phenyl]-2H-indazole-7-formamide
CN106467513A (en) * 2016-09-30 2017-03-01 陕西科技大学 A kind of synthetic method preparing Niraparib
CN106632244A (en) * 2016-09-30 2017-05-10 陕西科技大学 A novel synthetic method for preparing an anticancer medicine Niraparib
CN108201537A (en) * 2016-12-16 2018-06-26 苏州苏融生物医药有限公司 A kind of Ni Lapani sustained and controlled release medicaments composition and application thereof
WO2018183349A1 (en) * 2017-03-27 2018-10-04 Tesaro, Inc. Niraparib formulations
CN109081828B (en) 2017-06-14 2021-03-26 上海时莱生物技术有限公司 Poly (ADP-ribose) polymerase inhibitor, preparation method and application
MA50657A (en) 2017-09-26 2020-08-05 Tesaro Inc NIRAPARIB FORMULATIONS
CN108084157A (en) * 2018-02-12 2018-05-29 安庆奇创药业有限公司 A kind of synthetic method of Ni Lapani
CN108203404A (en) * 2018-03-02 2018-06-26 上海博邦医药科技有限公司 (R) synthetic method of -3- Phenylpiperidines or/and the chiral intermediate of (S) -3- Phenylpiperidines and Ni Lapani
EP4112049A1 (en) 2020-02-24 2023-01-04 Fukang (Shanghai) Health Technology Co., Ltd. Anti-coronavirus application of poly adp ribose polymerase inhibitor
CN115611860B (en) * 2021-07-13 2024-06-11 上海博璞诺科技发展有限公司 Method for synthesizing nilaparib

Also Published As

Publication number Publication date
LUC00072I2 (en) 2018-07-04
HUE044513T2 (en) 2019-10-28
DK2336120T3 (en) 2014-10-06
CN101578279B (en) 2013-07-17
NZ578256A (en) 2011-12-22
PE20081558A1 (en) 2008-10-30
ME03481B (en) 2020-01-20
UA97658C2 (en) 2012-03-12
HN2009001260A (en) 2012-03-26
ZA200903898B (en) 2010-04-28
ES2509115T3 (en) 2014-10-17
ES2728199T3 (en) 2019-10-22
ES2362214T3 (en) 2011-06-29
TWI528961B (en) 2016-04-11
LT2805945T (en) 2019-06-25
MY147789A (en) 2013-01-31
TW200836731A (en) 2008-09-16
DE602008005711D1 (en) 2011-05-05
SI2109608T1 (en) 2011-07-29
CN101578279A (en) 2009-11-11
PT2109608E (en) 2011-05-30
NI200900135A (en) 2010-08-30
CR10910A (en) 2010-01-19
PT2336120E (en) 2014-10-01
ATE502933T1 (en) 2011-04-15
PT2805945T (en) 2019-06-06
SI2336120T1 (en) 2014-10-30
GB0700432D0 (en) 2007-02-21

Similar Documents

Publication Publication Date Title
DK2109608T3 (en) Amide-substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors
EA200970674A1 (en) AMID-SUBSTITUTED INDASOLES AS POLY INHIBITORS (ADP-RYBOSE) POLYMERASE (PARP) INHIBITORS
MX2010005070A (en) Pyridazinone derivatives as parp inhibitors.
WO2007138351A3 (en) Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
MX2012002179A (en) Heterocyclic oxime compounds.
CR20110077A (en) DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL
WO2008103277A3 (en) Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
EA201190158A1 (en) Derivatives of benzofuranyl for use as glucose kinase inhibitors
BR112015002293A2 (en) dihydropyridone pi as xia factor inhibitors
EA201170521A1 (en) NEW CONNECTIONS
WO2008017883A3 (en) 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
MA32322B1 (en) Macrocyclic Urea and Sulphonamide Derivatives as Tafia Inhibitors
WO2011147951A8 (en) Cycloamino derivatives as gpr119 agonists
MX2011013869A (en) Anthelmintic agents and their use.
UY30585A1 (en) ISOSERINE DERIVATIVES AS INHIBITORS OF COAGULATION IXA FACTOR
MY148254A (en) Tartrate derivatives for use as coagulation factor ixa inhibitors
PH12015500418A1 (en) Pyridine derivative and medicine
TR201901937T4 (en) 8-methyl-1-phenyl-imidazole [1,5-a] pyrazine compounds.